Pausinystalia yomhinbe
Species
KNApSAcK Entry
| Organism name | Pausinystalia yomhinbe |
|---|---|
| Genus | Pausinystalia |
| Family | Rubiaceae |
| Kingdom | Plantae |
NCBI taxonomy
Entry
| Linked NCBI taxonomy name | Pausinystalia |
|---|---|
| Linked NCBI taxonomy ID | 170025 |
| Linked level | genus |
Family
| Family in NCBI taxonomy | Rubiaceae |
|---|---|
| ID | 24966 |
Kingdom (Superkingdom)
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
Plant class
| Plant class | asterids |
|---|---|
| ID | 71274 |
Metabolite list (1)
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
C00001789
|
Yohimbine
|
CHEMBL10347
CHEMBL15245 CHEMBL31410 CHEMBL196400 CHEMBL465600 CHEMBL1327758 CHEMBL1472740 CHEMBL1473950 CHEMBL1475803 CHEMBL1514351 CHEMBL1526082 CHEMBL1531132 CHEMBL1625779 CHEMBL2079555 |
D015016
|
130 / 91 / 76 | 6 / 58 | No. 229 | No. 4 |
|
Human Protein / Gene in interactions
130 ChEMBL Protein in interactions
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001789 | 1 / 0 |
| P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00001789 | 0 / 0 |
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00001789 | 0 / 0 |
| Q99700 | Ataxin-2 | Unclassified protein | C00001789 | 1 / 1 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001789 | 2 / 0 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001789 | 0 / 0 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001789 | 0 / 3 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001789 | 2 / 2 |
| P08246 | Neutrophil elastase | S1A | C00001789 | 2 / 1 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00001789 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001789 | 0 / 0 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001789 | 0 / 0 |
| P04062 | Glucosylceramidase | Enzyme | C00001789 | 6 / 4 |
| P29466 | Caspase-1 | C14 | C00001789 | 0 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00001789 | 0 / 0 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00001789 | 0 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00001789 | 2 / 2 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001789 | 0 / 0 |
| P02545 | Prelamin-A/C | Unclassified protein | C00001789 | 11 / 10 |
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00001789 | 3 / 2 |
| P10828 | Thyroid hormone receptor beta | NR1A2 | C00001789 | 3 / 1 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00001789 | 1 / 2 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001789 | 0 / 1 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001789 | 1 / 1 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00001789 | 0 / 0 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00001789 | 0 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001789 | 1 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001789 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001789 | 0 / 0 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001789 | 0 / 0 |
| P08183 | Multidrug resistance protein 1 | drug | C00001789 | 1 / 0 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001789 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00001789 | 0 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001789 | 0 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001789 | 0 / 1 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001789 | 1 / 8 |
| P11387 | DNA topoisomerase 1 | Isomerase | C00001789 | 0 / 0 |
| P11473 | Vitamin D3 receptor | NR1I1 | C00001789 | 2 / 3 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00001789 | 2 / 0 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001789 | 0 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001789 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00001789 | 0 / 0 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001789 | 0 / 0 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00001789 | 0 / 0 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001789 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001789 | 1 / 1 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001789 | 0 / 0 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001789 | 1 / 0 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00001789 | 0 / 0 |
| P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00001789 | 2 / 2 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001789 | 0 / 0 |
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00001789 | 0 / 0 |
| P39748 | Flap endonuclease 1 | Enzyme | C00001789 | 0 / 0 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001789 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00001789 | 0 / 0 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001789 | 0 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001789 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00001789 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00001789 | 0 / 0 |
| P35348 | Alpha-1A adrenergic receptor | Adrenergic receptor | C00001789 | 0 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00001789 | 1 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00001789 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00001789 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001789 | 0 / 0 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00001789 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001789 | 0 / 0 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001789 | 1 / 0 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001789 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00001789 | 0 / 0 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001789 | 1 / 0 |
| P03956 | Interstitial collagenase | M10A | C00001789 | 0 / 1 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001789 | 0 / 0 |
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00001789 | 7 / 3 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00001789 | 0 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00001789 | 0 / 1 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001789 | 2 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001789 | 0 / 0 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001789 | 0 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001789 | 2 / 0 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001789 | 5 / 9 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001789 | 1 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00001789 | 0 / 0 |
| P30304 | M-phase inducer phosphatase 1 | Ser_Thr_Tyr | C00001789 | 0 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001789 | 0 / 0 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001789 | 3 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001789 | 0 / 0 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001789 | 1 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00001789 | 0 / 0 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001789 | 2 / 1 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001789 | 0 / 0 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00001789 | 3 / 3 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001789 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00001789 | 1 / 1 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001789 | 1 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00001789 | 1 / 0 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001789 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001789 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00001789 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001789 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00001789 | 0 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00001789 | 0 / 0 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001789 | 0 / 0 |
| P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00001789 | 0 / 0 |
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00001789 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001789 | 1 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001789 | 0 / 1 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001789 | 0 / 0 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00001789 | 0 / 0 |
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00001789 | 0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001789 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00001789 | 4 / 3 |
| P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00001789 | 1 / 0 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001789 | 1 / 1 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001789 | 0 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00001789 | 0 / 0 |
| P35368 | Alpha-1B adrenergic receptor | Adrenergic receptor | C00001789 | 0 / 0 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001789 | 0 / 0 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001789 | 1 / 1 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00001789 | 0 / 1 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001789 | 0 / 0 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00001789 | 0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00001789 | 0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001789 | 0 / 0 |
| O00255 | Menin | Unclassified protein | C00001789 | 2 / 5 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001789 | 1 / 2 |
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00001789 | 0 / 1 |
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00001789 | 1 / 4 |
| Q9NY46 | Sodium channel protein type 3 subunit alpha | SCN alpha, NaV1.x | C00001789 | 0 / 0 |
| Q99250 | Sodium channel protein type 2 subunit alpha | SCN alpha, NaV1.x | C00001789 | 2 / 2 |
| P35498 | Sodium channel protein type 1 subunit alpha | SCN alpha, NaV1.x | C00001789 | 3 / 2 |
6 Gene in CTD interactions
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00001789
|
| 150 | ADRA2A, ADRA2, ADRA2R, ADRAR, ALPHA2AAR, ZNF32 | adrenoceptor alpha 2A |
C00001789
|
| 1082 | CGB, CGB3, CGB5, CGB7, CGB8, hCGB | chorionic gonadotropin, beta polypeptide |
C00001789
|
| 1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00001789
|
| 1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00001789
|
| 5617 | PRL | prolactin |
C00001789
|
Related Diseases
Diseases related to proteins in ChEMBL interactions
OMIM (91)
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 |
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| #300615 | Brunner syndrome |
P21397
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #162800 | Cyclic neutropenia |
P08246
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #607208 | Dravet syndrome |
P35498
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #613721 | Epileptic encephalopathy, early infantile, 11; eiee11 |
Q99250
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #608013 | Gaucher disease, perinatal lethal |
P04062
|
| #230800 | Gaucher disease, type i |
P04062
|
| #230900 | Gaucher disease, type ii |
P04062
|
| #231000 | Gaucher disease, type iii |
P04062
|
| #231005 | Gaucher disease, type iiic |
P04062
|
| #604403 | Generalized epilepsy with febrile seizures plus, type 2; gefsp2 |
P35498
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #137800 | Glioma susceptibility 1; glm1 |
P04626
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #603373 | Hyperthyroidism, familial gestational |
P16473
|
| #609152 | Hyperthyroidism, nonautoimmune |
P16473
|
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
| #612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 |
| #608516 | Major depressive disorder; mdd |
P08172
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #174800 | Mccune-albright syndrome; mas |
P63092
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #609634 | Migraine, familial hemiplegic, 3; fhm3 |
P35498
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
| #159900 | Myoclonic dystonia |
P14416
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #257200 | Niemann-pick disease, type a |
P17405
|
| #607616 | Niemann-pick disease, type b |
P17405
|
| #601665 | Obesity |
P32245
|
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #166350 | Osseous heteroplasia, progressive; poh |
P63092
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
|
| #168600 | Parkinson disease, late-onset; pd |
P04062
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
| #172700 | Pick disease of brain |
P10636
|
| #102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
| #601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
| #103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
| #603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
| #612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #607745 | Seizures, benign familial infantile, 3; bfis3 |
Q99250
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
| #274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
| #145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #112100 | Yt blood group antigen |
P22303
|
KEGG DISEASE (76)
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
|
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
| H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
| H00126 | Gaucher disease |
P04062
(related)
|
| H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
| H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00019 | Pancreatic cancer |
P04626
(related)
|
| H00027 | Ovarian cancer |
P04626
(related)
|
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
| H00342 | Tuberculosis |
P11473
(related)
|
| H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
| H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
| H01269 | Congenital hyperthyroidism |
P16473
(related)
|
| H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
| H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00775 | Familial or sporadic hemiplegic migraine |
P35498
(related)
|
| H00783 | Febrile seizures |
P35498
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
| H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
| H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
| H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
| H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
| H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
| H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00606 | Early infantile epileptic encephalopathy |
Q99250
(related)
|
| H00806 | Benign familial neonatal and infantile epilepsies |
Q99250
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
Diseases related to CTD interactions
58 disease in interactions with metabolites
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D017109 | Akathisia, Drug-Induced |
C00001789
|
| D000435 | Alcoholic Intoxication |
C00001789
|
| D000647 | Amnesia |
C00001789
|
| D001008 | Anxiety Disorders |
C00001789
|
| D001145 | Arrhythmias, Cardiac |
C00001789
|
| D001342 | Autonomic Nervous System Diseases |
C00001789
|
| D001714 | Bipolar Disorder |
C00001789
|
| D001919 | Bradycardia |
C00001789
|
| D001986 | Bronchial Spasm |
C00001789
|
| D002303 | Cardiac Output, Low |
C00001789
|
| D002375 | Catalepsy |
C00001789
|
| D023341 | Chills |
C00001789
|
| D019970 | Cocaine-Related Disorders |
C00001789
|
| D006970 | Disorders of Excessive Somnolence |
C00001789
|
| D003875 | Drug Eruptions |
C00001789
|
| D056486 | Drug-Induced Liver Injury |
C00001789
|
| D064420 | Drug-Related Side Effects and Adverse Reactions |
C00001789
|
| D004409 | Dyskinesia, Drug-Induced |
C00001789
|
| D007172 | Erectile Dysfunction |
C00001789
|
| D005099 | Exotropia |
C00001789
|
| D006930 | Hyperalgesia |
C00001789
|
| D006940 | Hyperemia |
C00001789
|
| D006943 | Hyperglycemia |
C00001789
|
| D006948 | Hyperkinesis |
C00001789
|
| D006966 | Hyperprolactinemia |
C00001789
|
| D006973 | Hypertension |
C00001789
|
| D018476 | Hypokinesia |
C00001789
|
| D007022 | Hypotension |
C00001789
|
| D007024 | Hypotension, Orthostatic |
C00001789
|
| D007859 | Learning Disorders |
C00001789
|
| D001523 | Mental Disorders |
C00001789
|
| D009069 | Movement Disorders |
C00001789
|
| D009127 | Muscle Rigidity |
C00001789
|
| D009203 | Myocardial Infarction |
C00001789
|
| D017202 | Myocardial Ischemia |
C00001789
|
| D015428 | Myocardial Reperfusion Injury |
C00001789
|
| D009207 | Myoclonus |
C00001789
|
| D009325 | Nausea |
C00001789
|
| D019954 | Neurobehavioral Manifestations |
C00001789
|
| D009765 | Obesity |
C00001789
|
| D009293 | Opioid-Related Disorders |
C00001789
|
| D016584 | Panic Disorder |
C00001789
|
| D011141 | Polyuria |
C00001789
|
| D012021 | Reflex, Abnormal |
C00001789
|
| D051437 | Renal Insufficiency |
C00001789
|
| D012640 | Seizures |
C00001789
|
| D012735 | Sexual Dysfunction, Physiological |
C00001789
|
| D020018 | Sexual Dysfunctions, Psychological |
C00001789
|
| D013313 | Stress Disorders, Post-Traumatic |
C00001789
|
| D019966 | Substance-Related Disorders |
C00001789
|
| D013375 | Substance Withdrawal Syndrome |
C00001789
|
| D013610 | Tachycardia |
C00001789
|
| D017180 | Tachycardia, Ventricular |
C00001789
|
| D014202 | Tremor |
C00001789
|
| D014474 | Unconsciousness |
C00001789
|
| D014693 | Ventricular Fibrillation |
C00001789
|
| D014839 | Vomiting |
C00001789
|
| D014987 | Xerostomia |
C00001789
|